My Research Interest in RESIST |
Respiratory Syncytial Virus (RSV) is the most common cause of lower respiratory tract infections in young children and a major cause of hospital admissions and health-care expenditures globally. One of our major scientific interests in RESIST is to identify susceptibility factors for severe RSV infections in infants and to find biomarkers that predict the course of the disease. The long-term goal is to develop preventive and therapeutic strategies for protection of infants and elderly people from severe RSV infections. Another major research focus is the identification of environmental factors that favour the development of a protective immunity in premature and mature babies with long term effects on a healthy life.
Prof. Hansen about her scientific work
Prof. Dr. Gesine Hansen – Curriculum Vitae
Current Position
Undergraduate and Postgraduate Training
Academic and Research Posts
Other Scientific Roles
Awards and Prizes
10 Selected Publications
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor. Sake, S. M., X. Y. Zhang, M. K. Rajak, M. Urbanek-Quaing, A. Carpentier, A. P. Gunesch, C. Grethe, A. Matthaei, J. Rückert, M. Galloux, T. Larcher, R. Le Goffic, F. Hontonnou, A. K. Chatterjee, K. Johnson, K. Morwood, K. Rox, W. A. M. Elgaher, J. B. Huang, M. Wetzke, G. Hansen, N. Fischer, J. F. Eléouët, M. A. Rameix-Welti, A. K. H. Hirsch, E. Herold, M. Empting, C. Lauber, T. F. Schulz, T. Krey, S. Haid, and T. Pietschmann. 2024. Nat Commun 15: 1173. PMID 38332002
Pathogen spectra in hospitalised and nonhospitalised children with community-acquired pneumonia. Wetzke, M., K. Schutz, M. V. Kopp, J. Seidenberg, C. Vogelberg, T. Ankermann, C. Happle, G. Voigt, H. Koster, T. Illig, C. Lex, A. Schuster, R. Maier, M. Panning, G. Barten, G. Rohde, T. Welte, and G. Hansen. 2023. ERJ Open Res 9. PMID 36923566
IRIS: Infection with Respiratory Syncytial Virus in infants – a prospective observational cohort study. Wetzke, M., D. Funken, M. Lange, L. Bejo, S. Haid, J. G. T. Monteiro, K. Schutz, C. Happle, T. F. Schulz, J. Seidenberg, T. Pietschmann, and G. Hansen. 2022. BMC Pulm Med 22: 88. PMID 35291998
IgA(+) memory B-cells are significantly increased in patients with asthma and small airway dysfunction. Habener, A., R. Grychtol, S. Gaedcke, D. DeLuca, A. M. Dittrich, C. Happle, M. Abdo, H. Watz, F. Pedersen, I. R. Konig, D. Thiele, M. V. Kopp, E. von Mutius, T. Bahmer, K. F. Rabe, A. Meyer-Bahlburg, G. Hansen, A. S. G. 2022. Eur Respir J 60. PMID 35595320
Regulatory B cells control airway hyperreactivity and lung remodeling in a murine asthma model. Habener, A., C. Happle, R. Grychtol, J. Skuljec, M. Busse, K. Daluge, H. Obernolte, K. Sewald, A. Braun, A. Meyer-Bahlburg, and G. Hansen. 2021. J Allergy Clin Immunol 147: 2281-2294 e2287. PMID 33249168
Pulmonary transplantation of human induced pluripotent stem cell-derived macrophages ameliorates pulmonary alveolar proteinosis. Happle, C., N. Lachmann, M. Ackermann, A. Mirenska, G. Göhring, K. Thomay, A. Mucci, M. Hetzel, T. Glomb, T. Suzuki, C. Chalk, S. Glage, O. Dittrich-Breiholz, B. Trapnell, T. Moritz, and G. Hansen. 2018. Am J Resp Crit Care 198: 350-360. PMID 29652170
B cells control maternofetal priming of allergy and tolerance in a murine model of allergic airway inflammation. Happle, C., A. C. Jirmo, A. Meyer-Bahlburg, A. Habener, H. G. Hoymann, C. Hennig, J. Skuljec, and G. Hansen. 2018. J Allergy Clin Immun 141: 685-696. PMID 28601684
Gene correction of human induced pluripotent stem cells repairs the cellular phenotype in pulmonary alveolar proteinosis. Lachmann, N., C. Happle, M. Ackermann, D. Luttge, M. Wetzke, S. Merkert, M. Hetzel, G. Kensah, M. Jara-Avaca, A. Mucci, J. Skuljec, A. M. Dittrich, N. Pfaff, S. Brennig, A. Schambach, D. Steinemann, G. Gohring, T. Cantz, U. Martin, N. Schwerk, G. Hansen*, and T. Moritz*. 2014. Am J Resp Crit Care 189: 167-182. PMID 24279725 (*equal contribution)
Pulmonary transplantation of macrophage progenitors as effective and long-lasting therapy for hereditary pulmonary alveolar proteinosis. Happle, C., N. Lachmann, J. Skuljec, M. Wetzke, M. Ackermann, S. Brennig, A. Mucci, A. C. Jirmo, S. Groos, A. Mirenska, C. Hennig, T. Rodt, J. P. Bankstahl, N. Schwerk, T. Moritz, and G. Hansen. 2014. Science Transl Med 6. PMID 25143363
Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway infmammation. Hansen G., G. Berry., RH DeKruyff, and DT Umetsu .1999. J Clin Invest 103. PMID 9916129